1. A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration. (October 2020) Authors: Moussa, C.; Torres-Yaghi, Y.; Pagan, F. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiac dysautonomia in Parkinson's Disease. (October 2020) Authors: Carwin, A.; Miri, S.; Nakano, S.; Anjum, M.; Mundel, E.; Starr, J.; Marsh, C.; Wilmarth, B.; Arellano, M.; Howard, H.; Hebron, M.; Torres-Yaghi, Y.; Moussa, C.; Pagan, F. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ChemInform Abstract: Isothermal Section of the Ternary Phase Diagram U—Fe—Ge at 900 °C and Its New Intermetallic Phases. Issue 29 (July 2015) Authors: Henriques, M. S; Berthebaud, D.; Lignie, A.; El Sayah, Z.; Moussa, C.; Tougait, O.; Havela, L.; Goncalves, A. P. Journal: ChemInform Issue: Volume 46:Issue 29(2015) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Influence of crystallographic orientation on the recrystallization of pure tantalum through microstructure-based estimation of the stored energy. (April 2022) Authors: Baton, J.; Geslin, W.; Moussa, C. Journal: International journal of refractory metals & hard materials Issue: Volume 104(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the CSF of individuals with Parkinson's disease. (October 2020) Authors: Torres-Yaghi, Y.; Pagan, F.; Moussa, C. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nilotinib increases brain dopamine and lowers CSF tau and oligomeric alpha-Synuclein in Parkinson's disease. (October 2020) Authors: Moussa, C.; Torres-Yaghi, Y.; Pagan, F. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nilotinib is reasonably safe and may halt the disease progression in moderately severe Parkinson's disease patients. (October 2020) Authors: Pagan, F.; Torres-Yaghi, Y.; Moussa, C. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rasmussen aneurysm: A forgotten complication of tuberculosis in the COVID-19 era. (2022) Authors: Mahmoud, N.; Moussa, C.; Attia, M.; Rouis, H.; Khattab, A.; Khouaja, I.; Zendah, I.; Hantous, S.; Maȃlej, S. Journal: Respiratory medicine case reports Issue: Volume 39(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The microbiome does not influence cartilage degradation following joint destabilisation in mice when performed under stringently controlled conditions. (April 2021) Authors: Miotla Zarebska, J.; Pearson, C.; Selby, J.; Moussa, C.; Scott, B.; dos Santos Duarte, C.; Vincent, T. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗